
October 15, 2024 – LanzaTech, a US-based bio-tech company focused on carbon recycling technology is expanding into producing nutritional protein from CO2 as a primary product.
The production of their ‘LanzaTech Nutritional Protein’ (LNP) will utilise a new microbe in its proprietary gas fermentations process. The ‘nutrient-rich’ and ‘cost-competitive’ protein reportedly uses a fraction of the average land and water resources that most protein sources use.
The centre for Aquaculture Technologies successfully tested the alternative protein for fish feed applications, whilst LanzaTech are currently in the process of completing trials for animal feed and petfood. They are also striving to be certified as safe (‘GRAS’) by the US Food and Drug Administration (FDA) for use in human nutrition.
The LNP Product has comparable properties to pea and whey protein, with 85 percent protein content, 20 amino acids, no allergenicity, whilst being highly digestible with an odourless and neutral colour.
In a company presentation regarding their ‘sustainable source of protein from CO2’ this October 2024, LanzaTech stated they have six commercial plants operating, four plus projects expected to reach FID and enter the construction phase during the 12 months, and a current >495,000 metric tonnes of CO2 recycled to date.
With nearly two decades of experience biorefining carbon-rich feedstocks to produce ethanol as the primary product and protein as a co-product at several commercial sites, LanzaTech are now evaluating potential sites, in collaboration with several partners, for the first pre commercial facilities, planned to be operational in 2026.
“Building on the expertise of our commercially operating core gas fermentation process, LNP represents a natural expansion of our business,” said Dr Jennifer Holmgren, CEO of LanzaTech.
“By coupling a new microbial production strain with our existing bioreactor technology, and our years of operating experience, we have developed a path to mass produce protein from CO2. For two years, we’ve operated a pilot facility to prepare for commercialisation, and in the process, we’ve partnered with leading brands and food testing organisations for rigorous analysis and prototyping of nutrition applications. We have now progressed into the engineering design phase for a 0.5 to 1.5 tonne per day facility, expected to be operational in 2026, and have developed a roadmap to commercial-scale production in 2028” states Dr Holmgren.
For more information, visit HERE.




































